Maureen Durkin is professor and chair of population health sciences and Waisman Center investigator at the University of Wisconsin-Madison. She received her undergraduate degree and Ph.D. in anthropology from the University of Wisconsin-Madison and her M.P.H. and Dr.P.H. degrees in epidemiology from Columbia University. Her research focuses on the epidemiology of neurodevelopmental disabilities and childhood injuries, both globally and within the United States. She has collaborated in the development of cross-cultural methods for epidemiologic studies of developmental disabilities and methods for surveillance of childhood injuries and disabilities. She has also directed international studies on the prevalence and causes of neurodevelopmental disabilities in low-income countries. Durkin is currently a principal investigator in the Autism and Developmental Disabilities Monitoring Network and other projects related to public health surveillance, epidemiology and care integration of autism and other developmental disabilities.
Maureen Durkin
Professor of population health sciences
University of Wisconsin-Madison
Explore more from The Transmitter
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.